Skip to main content
Clinical Trials/CTRI/2022/03/041186
CTRI/2022/03/041186
Not yet recruiting
Phase 3

Controlled clinical study to assess efficacy and safety of charkokta raktpachak yoga in treatment of dooshivishajanya kotha with special reference to urticaria.

Dr Suvarna S Kakde0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: L508- Other urticaria
Sponsor
Dr Suvarna S Kakde
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Suvarna S Kakde

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients diagnosed with Dushivishajanya kotha showing cardinal symptoms and suffering since one year
  • 2\. Patients having exposure to virrudha\-ahar, factory workers, farmers using pesticide
  • 3\. Patient ready to give consent

Exclusion Criteria

  • 1\. Age below 18 years and above 60 years
  • 2\. Patients with Diabetes mellitus and other systemic complications.
  • 3\.Patients of other skin diseases or injuries, burns or those under steroid therapy.
  • 4\. Pregnant and lactating mothers.
  • 5\. Patients with anaemia (Hb% \<8gm%)

Outcomes

Primary Outcomes

Not specified

Similar Trials